Gossamer Bio's market cap is currently $346.70M. The company's EPS TTM is $-0.329; its P/E ratio is ―; Gossamer Bio is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -4.38M	$ -4.43M	$ -5.17M	$ -4.27M	$ -3.09M
Operating Income	$ -183.76M	$ -218.59M	$ -216.12M	$ -233.96M	$ -186.14M
EBITDA	$ -172.15M	$ -211.07M	$ -209.32M	$ -233.96M	$ -186.14M
Net Income	$ -179.82M	$ -240.23M	$ -249.08M	$ -251.58M	$ -180.82M
Balance Sheet
Cash & Short-Term Investments	$ 296.43M	$ 255.68M	$ 325.22M	$ 512.63M	$ 401.83M
Total Assets	$ 311.92M	$ 272.45M	$ 343.66M	$ 539.43M	$ 426.60M
Total Debt	$ 212.46M	$ 225.74M	$ 185.24M	$ 183.73M	$ 39.55M
Net Debt	$ 180.35M	$ 113.77M	$ 1.83M	$ -302.32M	$ -95.54M
Total Liabilities	$ 249.15M	$ 260.37M	$ 222.19M	$ 218.75M	$ 74.12M
Stockholders' Equity	$ 62.77M	$ -1.03B	$ -811.53M	$ -577.53M	$ -334.17M
Cash Flow
Free Cash Flow	$ -159.16M	$ -187.51M	$ -190.51M	$ -201.24M	$ -151.40M
Operating Cash Flow	$ -159.16M	$ -187.03M	$ -188.89M	$ -176.36M	$ -144.83M
Investing Cash Flow	$ -110.97M	$ -1.03M	$ -117.43M	$ 215.34M	$ -147.14M
Financing Cash Flow	$ 190.15M	$ 117.09M	$ 3.33M	$ 312.54M	$ 321.58M

Currency in USD

Gossamer Bio Earnings and Revenue History

Income Statement >

Gossamer Bio Debt to Assets

Balance Sheet >

Gossamer Bio Cash Flow

Cash Flow >

Gossamer Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing